P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
10.31
-0.03 (-0.29%)
At close: Aug 21, 2026, 4:00 PM EDT
10.01
-0.30 (-2.91%)
After-hours: Aug 21, 2026, 7:42 PM EDT
P3 Health Partners Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,454 | 1,429 | 1,484 | 1,266 | 1,049 | 637.36 |
Other Revenue | 49.2 | 30.1 | 16.85 | - | - | - |
| 1,503 | 1,459 | 1,500 | 1,266 | 1,049 | 637.36 | |
Revenue Growth | 2.81% | -2.76% | 18.48% | 20.67% | 64.66% | 29.79% |
Cost of Revenue | 1,432 | 1,519 | 1,559 | 1,235 | 1,057 | 659.34 |
Gross Profit | 70.59 | -60.16 | -58.92 | 31.64 | -7.75 | -21.98 |
Selling, General & Admin | 116.77 | 107.23 | 120.13 | 125.6 | 162.38 | 119.41 |
Other Operating Expenses | 18.3 | 18.75 | 53.7 | -12.71 | -11.46 | 37.84 |
Operating Expenses | 219.22 | 210.14 | 259.88 | 199.57 | 238.21 | 165.97 |
Operating Income | -148.63 | -270.3 | -318.8 | -167.93 | -245.96 | -187.95 |
Interest Expense | -60.79 | -55.03 | -22.17 | -15.99 | -11.4 | -10.68 |
Other Non Operating Income (Expenses) | -17.67 | 4.44 | 23.57 | 0.18 | 12.62 | -5.72 |
EBT Excluding Unusual Items | -227.08 | -320.9 | -317.4 | -183.73 | -244.74 | -204.34 |
Impairment of Goodwill | - | - | - | - | -1,315 | - |
Gain (Loss) on Sale of Assets | -0.16 | -0.16 | 13.27 | - | - | - |
Asset Writedown | - | - | -8.06 | - | - | - |
Other Unusual Items | - | - | 6.2 | - | - | - |
Pretax Income | -227.25 | -321.06 | -305.99 | -183.73 | -1,560 | -204.34 |
Income Tax Expense | -10.76 | 2.03 | 4.39 | 2.7 | 1.86 | - |
Earnings From Continuing Operations | -216.48 | -323.09 | -310.38 | -186.43 | -1,562 | -204.34 |
Minority Interest in Earnings | 118.05 | 175.14 | 174.53 | 128.65 | 1,291 | 47.86 |
Net Income | -98.44 | -147.95 | -135.85 | -57.77 | -270.13 | -156.48 |
Preferred Dividends & Other Adjustments | 9.57 | - | - | - | - | -146.4 |
Net Income to Common | -108.01 | -147.95 | -135.85 | -57.77 | -270.13 | -10.08 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 3 | 3 | 3 | 2 | 1 | 1 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 6 | 1 | 1 |
Shares Change | 1.31% | 11.19% | -50.10% | 608.51% | - | -36.84% |
EPS (Basic) | -32.73 | -45.26 | -46.78 | -30.44 | -324.84 | -12.12 |
EPS (Diluted) | -32.73 | -45.26 | -54.06 | -31.64 | -325.00 | -12.12 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -130.52 | -91.24 | -110.13 | -77.86 | -128.25 | -69.88 |
Free Cash Flow Per Share | -39.55 | -27.91 | -37.46 | -13.21 | -154.23 | -84.03 |
Gross Margin | 4.70% | -4.12% | -3.93% | 2.50% | -0.74% | -3.45% |
Operating Margin | -9.89% | -18.52% | -21.25% | -13.26% | -23.44% | -29.49% |
Profit Margin | -7.19% | -10.14% | -9.05% | -4.56% | -25.74% | -1.58% |
Free Cash Flow Margin | -8.69% | -6.25% | -7.34% | -6.15% | -12.22% | -10.96% |
EBITDA | -64.48 | -186.14 | -232.74 | -81.26 | -158.67 | -179.22 |
EBITDA Margin | -4.29% | -12.76% | -15.51% | -6.42% | -15.12% | -28.12% |
D&A For EBITDA | 84.15 | 84.16 | 86.06 | 86.68 | 87.29 | 8.72 |
EBIT | -148.63 | -270.3 | -318.8 | -167.93 | -245.96 | -187.95 |
EBIT Margin | -9.89% | -18.52% | -21.25% | -13.26% | -23.44% | -29.49% |
Revenue as Reported | 1,503 | 1,459 | 1,500 | 1,266 | 1,049 | 637.36 |
Advertising Expenses | - | 0.9 | 1.3 | 3.2 | 4.5 | 2.1 |